Ascendis Pharma A/S (ASND) Competitors

argenx (NASDAQ:ARGX) and Ascendis Pharma A/S (NASDAQ:ASND) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, community ranking, dividends, risk, media sentiment, institutional ownership, earnings, profitability and analyst recommendations.

Does the media prefer ARGX or ASND?

In the previous week, Ascendis Pharma A/S had 7 more articles in the media than argenx. MarketBeat recorded 12 mentions for Ascendis Pharma A/S and 5 mentions for argenx. argenx's average media sentiment score of 0.80 beat Ascendis Pharma A/S's score of 0.79 indicating that argenx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
argenx	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Ascendis Pharma A/S	5 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts recommend ARGX or ASND?

argenx presently has a consensus target price of $709.18, suggesting a potential upside of 22.57%. Ascendis Pharma A/S has a consensus target price of $217.73, suggesting a potential upside of 25.11%. Given Ascendis Pharma A/S's higher probable upside, analysts plainly believe Ascendis Pharma A/S is more favorable than argenx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
argenx	0 Sell rating(s)	1 Hold rating(s)	19 Buy rating(s)	2 Strong Buy rating(s)	3.05
Ascendis Pharma A/S	0 Sell rating(s)	0 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do institutionals & insiders have more ownership in ARGX or ASND?

60.3% of argenx shares are held by institutional investors. 2.4% of argenx shares are held by company insiders. Comparatively, 40.0% of Ascendis Pharma A/S shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Which has preferable earnings & valuation, ARGX or ASND?

argenx has higher revenue and earnings than Ascendis Pharma A/S. Ascendis Pharma A/S is trading at a lower price-to-earnings ratio than argenx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
argenx	$2.58B	13.69	-$295.05M	$16.21	35.69
Ascendis Pharma A/S	$368.70M	28.78	-$409.12M	-$6.28	-27.71

Does the MarketBeat Community prefer ARGX or ASND?

argenx received 209 more outperform votes than Ascendis Pharma A/S when rated by MarketBeat users. Likewise, 67.58% of users gave argenx an outperform vote while only 67.26% of users gave Ascendis Pharma A/S an outperform vote.

Company	Underperform	Outperform
argenx	Outperform Votes 665 67.58%	Underperform Votes 319 32.42%
Ascendis Pharma A/S	Outperform Votes 456 67.26%	Underperform Votes 222 32.74%

Is ARGX or ASND more profitable?

argenx has a net margin of -2.11% compared to Ascendis Pharma A/S's net margin of -104.54%. Ascendis Pharma A/S's return on equity of 0.00% beat argenx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
argenx	-2.11%	-1.45%	-1.29%
Ascendis Pharma A/S	-104.54%	N/A	-39.23%

Which has more risk and volatility, ARGX or ASND?

argenx has a beta of 0.39, meaning that its stock price is 61% less volatile than the S&P 500. Comparatively, Ascendis Pharma A/S has a beta of 0.37, meaning that its stock price is 63% less volatile than the S&P 500.

Summary

argenx beats Ascendis Pharma A/S on 13 of the 19 factors compared between the two stocks.